Challenges of transarterial therapy for hepatocellular carcinoma in patients with chronic kidney disease

Poor outcomes of hepatocellular carcinomas (HCC) in chronic kidney disease (CKD) patients are well described. Transarterial therapy is the standard treatment for HCC, following which regular contrast-enhanced imaging for residual disease is recommended. CKD is considered a relative contraindication...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Wei-Chen, Chang, Chen-Wang, Chang, Ching-Wei, Wang, Tsang-En, Chen, Ming-Jen, Wang, Horng-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736401/
https://www.ncbi.nlm.nih.gov/pubmed/31464957
http://dx.doi.org/10.1097/MD.0000000000017007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736401/
https://www.ncbi.nlm.nih.gov/pubmed/31464957
http://dx.doi.org/10.1097/MD.0000000000017007

Ejemplares similares